NY-BR-1 can be better than mammaglobin as a differentiation antigen if metastasis from breast carcinoma is suspected

Conclusion: NY-BR-1 can aid the identification of mammary origin of metastatic carcinoma and it could be more useful than mammaglobin as a differentiation antigen.

Source: Egyptian Journal of Pathology - July 1, 2014 Category: Pathology Tags: Original Articles Source Type: research